Literature DB >> 6839758

Comparison of different prostaglandin analogues and laminaria for preoperative dilatation of the cervix in late first trimester abortion.

N J Christensen, M Bygdeman, K Gréen.   

Abstract

The present study included 550 mainly primiparous women in the 8th to 12th week of pregnancy admitted to the hospital for termination of pregnancy. The patients were treated by different prostaglandin analogues or one medium size laminaria tent followed by vacuum aspiration. The treatment period was three hours, which for some analogues was extended to six and twelve hours. The prostaglandins studied were 15-methyl PGF2 alpha methyl ester (0.5 and 1.0 mg), 16,16-dimethyl-trans-delta 2 PGE1 methyl ester (1.0 mg), 9-deoxo-16,16-dimethyl-9-methylene PGE2 (30 mg), all administered by the vaginal route, and 16-phenoxy-omega-17,18, 19,20-tetranor PGE2 methyl sulfonylamide (0.25 and 0.5 mg) given as i.m. injections. At operation the degree of cervical dilatation, the amount of blood loss and other operative complications were registered. The patients were continuously supervised during treatment and during at least three hours after operation. Side effects, complications and vital signs were recorded. The degree of cervical dilatation was related to the duration of prostaglandin treatment. If the duration of prostaglandin treatment was prolonged, the frequency of gastrointestinal side effects, abortion prior to scheduled time for vacuum aspiration and pain needing analgesic treatment also increased. Both the efficacy and the frequency of side effects were dose dependent. The outcome of therapy after three-hour pretreatment was evaluated. All the prostaglandins were more effective than one medium size laminaria tent in dilating the cervical canal. The three E analogues were most effective. The number of patients with bleeding at operation of 50 ml or more was also higher following laminaria than following prostaglandin pretreatment. Most advantageous in this respect were the three E analogues. Frequency of gastrointestinal side effects and degree of pain following 9-methylene PGE2 and 16,16-dimethyl PGE1 methyl ester was the same as following laminaria treatment.

Entities:  

Keywords:  Abortifacient Agents; Abortion, Drug Induced; Abortion, Induced; Age Factors; Biology; Bleeding; Cervical Dilatation; Cervical Effects; Cervix; Comparative Studies; Endocrine System; Evaluation; Family Planning; Fertility Control, Postconception; Gastrointestinal Effects; Genitalia; Genitalia, Female; Laminaria Tents--administraction and dosage; Nulliparity; Physiology; Pregnancy; Pregnancy, First Trimester; Prostaglandins--administraction and dosage; Reproduction; Research Methodology; Studies; Treatment; Urogenital System; Uterus; Vaginal Suppository

Mesh:

Substances:

Year:  1983        PMID: 6839758     DOI: 10.1016/0010-7824(83)90055-0

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  6 in total

Review 1.  Medical termination of pregnancy.

Authors:  J Guillebaud
Journal:  BMJ       Date:  1990 Aug 18-25

2.  A comparison of Lamicel tents and gemeprost (Cervagem) pessaries prior to first trimester abortion.

Authors:  I Stornes; K L Rasmussen
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

Review 3.  A risk-benefit assessment of oxytocics in obstetric practice.

Authors:  M Winkler; W Rath
Journal:  Drug Saf       Date:  1999-04       Impact factor: 5.606

Review 4.  Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors:  R N Brogden; K L Goa; D Faulds
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

5.  Gemeprost for first trimester missed abortion.

Authors:  C Egarter; J Lederhilger; C Kurz; H Karas; K Reisenberger
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

6.  Intravaginal isonicotinic acid hydrazide (INH) versus misoprostol for cervical ripening prior to hysteroscopy.

Authors:  Ladan Haghighi; Zahra Najmi; Samaneh Rokhgireh; Yousef Moradi
Journal:  Obstet Gynecol Sci       Date:  2020-06-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.